All In MedTech

FDA Clearance Tracker · P200031-S006

Organ Care System (OCS®) Liver™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 23, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 23, 2024

Approved

Time to decision

177 days

Received Aug 30, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P200031-S006
Device name
Organ Care System (OCS®) Liver™
Applicant location
Andover, MA
Received
Aug 30, 2023
Decided
Feb 23, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P200031

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for labeling changes including the research methods and results of the 2-year PROTECT CAP Continuation PAS.

Source documents

Other decisions for TransMedics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.